Case number 2020-2137
Cephalon, Inc. v. Slayback Pharma Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 13, 2021 | 15 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [792414] [20-2134, 20-2137] [MJL] [Entered: 08/13/2021 09:19 AM] (2) |
| Dec 4, 2020 | 14 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Mylan Laboratories Limited, Certificate of Interest [13], is not in compliance with the rules of this court (see attached). Service as of this date by the Clerk of Court. [740448] [KMH] [Entered: 12/04/2020 04:22 PM] (1) |
| Dec 3, 2020 | 13 | Certificate of Interest for Appellant Mylan Laboratories Limited. Service: 12/03/2020 by email. [740130] [20-2137] [Nicole Stafford] [Entered: 12/03/2020 04:53 PM] (3) |
| Aug 24, 2020 | 11 | ORDER consolidating appeals 20-2134, 20-2136, and 20-2137. Appellants' opening briefs are due no later than October 5, 2020. Service as of this date by the Clerk of Court. [716929] [20-2134, 20-2136, 20-2137] [KMH] [Entered: 08/24/2020 12:44 PM] (2) |
| Aug 24, 2020 | 12 | Note to File: The following cases are consolidated: 20-2134 Lead with 20-2136 and 20-2137 Consolidated Member Cases. The parties must file all documents in the lead appeal only. [716966] [20-2134, 20-2136, 20-2137] [KMH] [Entered: 08/24/2020 01:37 PM] (0) |
| Aug 20, 2020 | 3 | Entry of appearance for David I. Berl; Adam D. Harber; Shaun P. Mahaffy; Ben Picozzi; Matthew W. Lachman as counsel for Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716184] [20-2137] [Ben Picozzi] [Entered: 08/20/2020 01:41 PM] (2) |
| Aug 20, 2020 | 4 | Certificate of Interest for Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716185] [20-2137] [Ben Picozzi] [Entered: 08/20/2020 01:43 PM] (3) |
| Aug 20, 2020 | 5 | Docketing Statement for the Appellees Cephalon, Inc. and Teva Pharmaceuticals International GmbH. Service: 08/20/2020 by email. [716186] [20-2137] [Ben Picozzi] [Entered: 08/20/2020 01:46 PM] (2) |
| Aug 20, 2020 | 6 | Entry of appearance for Daniel G. Brown; Marc N. Zubick; Kenneth G. Schuler; Gabriel K. Bell as counsel for Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716245] [20-2137] [Daniel Brown] [Entered: 08/20/2020 03:11 PM] (2) |
| Aug 20, 2020 | 7 | Certificate of Interest for Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716246] [20-2137] [Daniel Brown] [Entered: 08/20/2020 03:14 PM] (3) |
| Aug 20, 2020 | 8 | Docketing Statement for the Appellee Eagle Pharmaceuticals, Inc.. Service: 08/20/2020 by email. [716247] [20-2137] [Daniel Brown] [Entered: 08/20/2020 03:15 PM] (2) |
| Aug 20, 2020 | 9 | Certificate of Interest for Appellant Mylan Laboratories Limited. Service: 08/20/2020 by email. [716364] [20-2137] [Nicole Stafford] [Entered: 08/20/2020 06:24 PM] (3) |
| Aug 20, 2020 | 10 | Docketing Statement for the Appellant Mylan Laboratories Limited. Service: 08/20/2020 by email. [716366] [20-2137] [Nicole Stafford] [Entered: 08/20/2020 06:26 PM] (2) |
| Aug 10, 2020 | 2 | Entry of appearance for Nicole W. Stafford; Dennis Gregory; Aden Allen; David Steuer as counsel for Appellant Mylan Laboratories Limited. Service: 08/10/2020 by email. [713777] [20-2137] [Nicole Stafford] [Entered: 08/10/2020 02:48 PM] (2) |
| Aug 6, 2020 | 1 | Appeal docketed. Received: 08/05/2020. [713041]Entry of Appearance is due on 08/20/2020. Certificate of Interest is due on 08/20/2020. Docketing Statement is due on 08/20/2020. Appellant's brief is due on 10/05/2020. [KMH] [Entered: 08/06/2020 01:27 PM] (143) |
